News from ECHA
| New CLP hazard classes will be included in IUCLID From 29 April 2024, companies can start including information on new hazard classes in their IUCLID dossiers, following the amendment of the Classification, Labelling and Packaging (CLP) Regulation. |
|---|
|
|---|
|
|---|
|
ECHA
Deadline extended: Become part of ECHA's Committee for Socio-Economic Analysis The call for co-opted members for our Committee for Socio-Economic Analysis has been extended. We are looking for senior experts in: substitution of substances of very high concern and analysis of alternatives, as well as socio-economic analysis.Read more on our website and express your interest until noon 22 April 2024 to join the EU’s key committees on chemical safety. |
|---|
|
|---|
|
|---|
|
Enforcement
Stakeholder workshop on enforcing biocidal active substances On 25 March 2024, we organised a workshop to our accredited stakeholders on the results and recommendations of the harmonised enforcement project on biocides (BEF-2). During the project, the national enforcement authorities checked biocidal products with approved and non-approved active substances.
The agenda, presentations and conclusions from the workshop are now available on our website.
|
|---|
|
|---|
|
|---|
|
Board of Appeal
Substance evaluation decision annulled Case A-008-2022 concerns a substance evaluation decision on 5-amino-o-cresol requesting an in vivo mammalian alkaline comet assay (OECD TG 489). The request was based on a concern related to mutagenicity (chromosomal aberration and gene mutation).
The appellant’s arguments that ECHA committed errors in requesting information to clarify a concern related to gene mutation were rejected.
However, the Board of Appeal found that the Agency had failed to demonstrate that there is a potential risk related to chromosomal aberration. The contested decision was therefore annulled and the case remitted to ECHA for further action.
|
|---|
|
|---|
|
|---|
